首页> 外文期刊>Journal of International Medical Research >Feasibility of using oxycodone as the sole opioid for induction and maintenance of general anaesthesia in minor/moderate surgery: a prospective, observational, descriptive study
【24h】

Feasibility of using oxycodone as the sole opioid for induction and maintenance of general anaesthesia in minor/moderate surgery: a prospective, observational, descriptive study

机译:使用羟考酮作为唯一的诱导和维护诱导和维护次要/中等手术的唯一的阿片类药物:一种预期,观察,描述性研究

获取原文
           

摘要

Objectives This study presented the feasibility of oxycodone as the sole opioid for general anaesthesia in minor/moderate surgery. Methods In this prospective, observational, descriptive study, 62 patients were enrolled and received intravenous oxycodone as the sole opioid for the induction and maintenance of general anaesthesia. We observed all of these patients to determine whether oxycodone alone could provide sufficient intraoperative and postoperative analgesia, as well as to record the extubation times and adverse events. Results A total oxycodone dose of 0.316?±?0.05?mg/kg was used for induction and maintenance of general anaesthesia. The dose could maintain haemodynamic stability during surgery and good postoperative analgesia. Oxycodone caused deep sedation (nine patients had Ramsey sedation scores ≥4), leading to respiratory depression and long stays in the post-anaesthesia care unit (PACU). The extubation time (16.9?±?6.4 minutes) increased with increasing oxycodone doses. Conclusion Oxycodone can be used as the sole opioid for general anaesthesia in minor/moderate surgery. However, care should be taken because of its deep sedation effect. Trial registration: This study is registered at the Chinese Clinical Trial Registry ( www.chictr.org.cn ): ChiCTR-opc-16009175
机译:目的本研究介绍了羟考酮作为少数/中等手术中全身麻醉的唯一阿片类药物的可行性。在这种前瞻性,观察性,描述性研究中,62名患者的方法是纳入和接受静脉内羟考酮作为全身麻醉诱导和维持的唯一阿片类药物。我们观察到所有这些患者确定羟考酮是否可以提供足够的术中和术后镇痛,以及记录拔管时间和不良事件。结果总羟考酮剂量为0.316?±0.05?Mg / kg用于诱导和维持全身麻醉。剂量可以在手术和良好的术后镇痛期间保持血液动力学稳定性。羟考酮引起深镇静(9名患者有Ramsey Sedation评分≥4),导致呼吸抑郁症和长期停留在麻醉后护理单位(PACU)。随着羟考酮剂量的增加,拔光时间(16.9?±6.4分钟)增加。结论羟考酮可用作轻微/中等手术中全身麻醉的唯一阿片类药物。但是,由于其深度镇静效应,应注意。审判登记:本研究在中国临床试验登记处注册(www.chictr.org.cn):Chictr-opc-16009175

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号